Skip to main content
profile image
Selected Works of Santiago Aparo
Article
Excision Repair Cross-complementing Group-1 (ERCC1) Induction and Polymorphism are Markers of inferior outcome in Patients with Colorectal Cancer Treated with Oxaliplatin
Cancer Research. Proceedings. / American Cancer Association for Cancer Research. Annual Meeting (2019)
  • Santiago Aparo, Baptist Health South Florida
  • Devika Rao
  • A. B. Mallick
  • T. Augustine
  • C. Daroqui
  • J. Jiffry
  • A. Merla
Link
Disciplines
Publication Date
2019
Citation Information
Santiago Aparo, Devika Rao, A. B. Mallick, T. Augustine, et al.. "Excision Repair Cross-complementing Group-1 (ERCC1) Induction and Polymorphism are Markers of inferior outcome in Patients with Colorectal Cancer Treated with Oxaliplatin" Cancer Research. Proceedings. / American Cancer Association for Cancer Research. Annual Meeting Vol. 79 Iss. 23 (2019) p. 4932 - 4932
Available at: http://works.bepress.com/santiago-aparo/42/